Supported by the W.M. Keck Foundation and Seth MacFarlane Foundation
What is the USC COVID-19 Biospecimen Repository (Biorepository)?
The USC COVID-19 Biospecimen Repository (Biorepository) houses blood, saliva, urine, and/or tissue samples from patients who have confirmed positivity for COVID-19. This biorepository enables basic, translational, and clinical research in patients who have had COVID-19. The biorepository facilitates the study of the natural history, disease progression, and treatment response in patients with COVID-19. Samples from control patients are also collected. The specimens are banked for current and future research.